000 | 00891 a2200265 4500 | ||
---|---|---|---|
005 | 20250513194927.0 | ||
264 | 0 | _c20000202 | |
008 | 200002s 0 0 eng d | ||
022 | _a0959-8138 | ||
024 | 7 |
_a10.1136/bmj.319.7220.1298 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDonald, A | |
245 | 0 | 0 |
_aTechnology transfer: the problem with "trickle down" theory. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cNov 1999 |
||
300 |
_a1298-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aDeveloping Countries |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 | _aDrug Industry |
650 | 0 | 4 | _aDrugs, Essential |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aTechnology Transfer |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 319 _gno. 7220 _gp. 1298-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.319.7220.1298 _zAvailable from publisher's website |
999 |
_c10515394 _d10515394 |